Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin™) to chemotherapy improves survival in metastatic colorectal cancer

Amy D'Orazio; David Lee; Lee Ellis; Edward Chu

doi:10.1016/S1533-0028(11)70071-8

Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin™) to chemotherapy improves survival in metastatic colorectal cancer

Amy D'Orazio, David Lee, Lee Ellis, Edward Chu

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	85-88
Number of pages	4
Journal	Clinical colorectal cancer
Volume	3
Issue number	2
DOIs	https://doi.org/10.1016/S1533-0028(11)70071-8
State	Published - Aug 2003
Externally published	Yes

ASJC Scopus subject areas

Oncology
Gastroenterology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1533-0028(11)70071-8

Cite this

@article{b2e15d4e5b754ea58d1466b69b8f34b1,

title = "Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin{\texttrademark}) to chemotherapy improves survival in metastatic colorectal cancer",

author = "Amy D'Orazio and David Lee and Lee Ellis and Edward Chu",

year = "2003",

month = aug,

doi = "10.1016/S1533-0028(11)70071-8",

language = "English (US)",

volume = "3",

pages = "85--88",

journal = "Clinical colorectal cancer",

issn = "1533-0028",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin™) to chemotherapy improves survival in metastatic colorectal cancer

AU - D'Orazio, Amy

AU - Lee, David

AU - Ellis, Lee

AU - Chu, Edward

PY - 2003/8

Y1 - 2003/8

UR - http://www.scopus.com/inward/record.url?scp=0041381022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041381022&partnerID=8YFLogxK

U2 - 10.1016/S1533-0028(11)70071-8

DO - 10.1016/S1533-0028(11)70071-8

M3 - Article

C2 - 12952562

AN - SCOPUS:0041381022

SN - 1533-0028

VL - 3

SP - 85

EP - 88

JO - Clinical colorectal cancer

JF - Clinical colorectal cancer

IS - 2

ER -

Adding a humanized antibody to vascular endothelial growth factor (Bevacizumab, Avastin™) to chemotherapy improves survival in metastatic colorectal cancer

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this